Project Grant RM1DA064502
- This $643,285 Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a multisite study to assess the reach, effectiveness, and implementation of three different models of Oregon's new "deflection" programs. Deflection programs are partnerships between public safety and public health agencies that aim to divert people with substance use disorder away from the criminal justice system and...
- The federal Project Grant award of $121,887 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to examine the performance of statistical methodologies, such as multilevel modeling (MLM) and dynamic structural equation modeling (DSEM), in testing dynamic theories of substance use. The research aims to address the integration of theory and methods to build reliable and valid theories of substance use, as the rapid...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $444,826, is focused on adapting and testing an innovative, trauma-informed intervention to reduce overdose risk among women re-entering the community from prison. The key activities include: 1) Adapting the Trust-Based Relational Intervention (TBRI) approach by engaging stakeholders to align it with the unique needs of justice-involved women,...
- This federal Project Grant award of $769,708 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is for the "Drug Use and Addiction Research Programs" (CFDA 93.279). The award supports research to adapt and pilot test the Brief Negotiation Interview (BNI) for use among assault-injured emerging adults (ages 18-25) with alcohol and/or cannabis misuse who seek care in the emergency department setting. Key objectives include eliciting shared...
- This $181,681 federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH Drug Use and Addiction Research Programs (CFDA 93.279), aims to integrate a harm reduction-focused behavioral intervention into the Formerly Incarcerated Transition (FIT) primary care program. The grant will fund a three-part research study to: 1) Identify barriers and facilitators to implementing the harm reduction therapy in a primary care setting through qualitative interviews; 2)...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is funded under the Drug Use and Addiction Research Programs (CFDA 93.279). The $660,104 award, with a performance period from August 15, 2025 to July 31, 2027, will be used by The University of Texas Southwestern Medical Center (UT Southwestern) to assess the impact of adding personalized contingency management via a mobile app (DynamiCare) to a patient navigator...
- This $1,653,005 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the "Community Paramedic Response and Overdose Outreach with Supportive Medical-Legal Services (CROSSROADS) Study" at Duke University. The project aims to deploy non-armed community paramedics as first responders for overdose calls, providing life-saving interventions, medication-assisted treatment, and linkages to...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award in the amount of $688,271, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a research project led by Yale University to examine spatial and temporal variability in a state's illicit drug market. The key products and services to be delivered under this grant include: Expanding existing street-based testing of drug samples from representative samples of people who use drugs (PWUD)...
- The National Institute on Drug Abuse (NIDA) has awarded a $731,275 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMMS) to support the "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" study. The 5-year study will evaluate the effectiveness of the "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice Version (MISSION-CJ)"...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,474,264 to Texas Christian University (TCU) to conduct a hybrid implementation research study on deflection and pre-arrest diversion initiatives. The study aims to: 1) enhance understanding of public health and safety outcomes associated with deflection programs, and 2) advance knowledge on effective implementation strategies involving community engagement in deflection. The highly experienced research team will carry out a randomized controlled trial across 20 communities in 5 states to test the implementation-effectiveness of two strategy bundles for promoting deflection models. The study will run from Sep 2025 to May 2030, with the goal of generating findings to inform best practices for implementing deflection programs and improving opioid and stimulant-related outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.5m | 8/27/25 |